Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Literature DB >> 22262022

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Marianne Pavel¹, Eric Baudin, Anne Couvelard, Eric Krenning, Kjell Öberg, Thomas Steinmüller, Martin Anlauf, Bertram Wiedenmann, Ramon Salazar.

Abstract

Entities: Disease Species

Mesh：

Year: 2012 PMID： 22262022 DOI： 10.1159/000335597

Source DB: PubMed Journal: Neuroendocrinology ISSN： 0028-3835 Impact factor: 4.914

Keyword Cloud
Cited

× No keyword cloud information.

249 in total

1. Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study.

Authors: Lingaku Lee; Hisato Igarashi; Nao Fujimori; Masayuki Hijioka; Ken Kawabe; Yoshinao Oda; Robert T Jensen; Tetsuhide Ito
Journal: Jpn J Clin Oncol Date: 2015-09-15 Impact factor: 3.019

2. The efficacy of (177)Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumours: a meta-analysis.

Authors: Seong-Jang Kim; Kyoungjune Pak; Phillip J Koo; Jennifer J Kwak; Samuel Chang
Journal: Eur J Nucl Med Mol Imaging Date: 2015-08-09 Impact factor: 9.236

Review 3. Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.

Authors: Marco Gallo; Pasqualino Malandrino; Giuseppe Fanciulli; Francesca Rota; Antongiulio Faggiano; Annamaria Colao
Journal: J Cancer Res Clin Oncol Date: 2017-04-12 Impact factor: 4.553

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

1. Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study.

2. The efficacy of (177)Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumours: a meta-analysis.

Review 3. Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.

4. CUP Syndrome in Neuroendocrine Neoplasia: Analysis of Risk Factors and Impact of Surgical Intervention.

5. Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors.

Review 6. Practical management and treatment of pancreatic neuroendocrine tumors.

7. Ki-67 is a reliable pathological grading marker for neuroendocrine tumors.

Review 8. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.

Review 9. The treatment of hyperinsulinemic hypoglycaemia in adults: an update.

10. Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of Everolimus.